Pablo Monedero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Pablo Monedero has a total of 960 co-authors. Here are the top co-authors by number of shared publications:
- Jose Ramon Perez Valdivieso
Departamento de Anestesia y Reanimación, Clínica Universidad de Navarra, Universidad de Navarra, Pamplona, España
11 shared publications - Maira Bes-Rastrollo
Department of Preventive Medicine and Public Health, University of Navarra, Pamplona, Spain
10 shared publications - Nuria Garcia-Fernandez
Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain
10 shared publications J. Canet
Department of Anesthesiology and Postoperative Care, Hospital Universitari Germans Trias I Pujol, Barcelona, Spain
7 shared publicationsF Carrascosa
6 shared publicationsF García-Pedrajas
6 shared publications
Latest Publications
- 10 April 2026
- Published by Elsevier in Revista Española de Anestesiología y Reanimación (English Edition)
- Vol. 73 (5) , 502052
Training in cardiopulmonary resuscitation among anesthesiology residents in Spain: results of a national survey
- 10 April 2026
- Published by Elsevier in Revista Española de Anestesiología y Reanimación (English Edition)
- Vol. 73 (5) , 502052
Training in cardiopulmonary resuscitation among anesthesiology residents in Spain: results of a national survey
- Open Access
- 9 February 2026
- Published by Elsevier in Revista Española de Anestesiología y Reanimación
Formación en reanimación cardiopulmonar de los residentes de anestesiología en España: resultados de una encuesta nacional
- 9 February 2026
- Published by Elsevier in Revista Española de Anestesiología y Reanimación
Open AccessFormación en reanimación cardiopulmonar de los residentes de anestesiología en España: resultados de una encuesta nacional
- Open Access
- 23 May 2025
- Published by Elsevier in Revista Española de Anestesiología y Reanimación
- Vol. 72 (7)
Lesión renal aguda postoperatoria en cirugía mayor abdominal. Utilidad del biomarcador urinario [TIMP-2] × [IGFBP7] (NephroCheck®)
- 23 May 2025
- Published by Elsevier in Revista Española de Anestesiología y Reanimación
- Vol. 72 (7)
Open AccessLesión renal aguda postoperatoria en cirugía mayor abdominal. Utilidad del biomarcador urinario [TIMP-2] × [IGFBP7] (NephroCheck®)
- 17 February 2025
- Published by BMJ in BMJ Supportive & Palliative Care
- Vol. 15 (4) , 518-521
Mortality predictors for ICU end-of-life decisions: delta-SOFA and SAPS 3 – retrospective evaluation
Objectives End-of-life decisions in intensive care units (ICUs) are complex, influenced by patient severity, treatment efficacy and resource constraints. This study assessed the predictive value of delta-Sequential Organ Failure Assessment (SOFA) scores on days 2, 3 and 5, both independently and combined with Simplified Acute Physiology Score (SAPS) 3, for in-hospital mortality. Methods A retrospective cohort study analysed ICU patients with stays of≥5 days from 2018 to 2020. Clinical data included SAPS 3 and SOFA scores at admission, 48 hours and on days 3 and 5, alongside mortality outcomes. Logistic regression and discriminant analysis identified mortality predictors and evaluated model performance. Results Among 200 patients, 26% died in hospital. Non-survivors had significantly higher SAPS 3 scores (mean 51.9±11.9 vs 45.6±11.9 in survivors, p=0.001) and worsening SOFA scores, particularly on days 3 and 5. Combining SAPS 3 with delta-SOFA on day 5 produced an area under the receiver operating characteristic (AUROC) of 0.71 (95% CI: 0.63 to 0.79), indicating moderate predictive ability. Conclusions Integrating the delta-SOFA score on day 5 with SAPS 3 improves in-hospital mortality predictions during prolonged ICU stays. Findings suggest early treatment limitations within 48 hours may be premature, as patient responses evolve and shared decision-making becomes more feasible over time.
- 17 February 2025
- Published by BMJ in BMJ Supportive & Palliative Care
- Vol. 15 (4) , 518-521
Mortality predictors for ICU end-of-life decisions: delta-SOFA and SAPS 3 – retrospective evaluation
Objectives End-of-life decisions in intensive care units (ICUs) are complex, influenced by patient severity, treatment efficacy and resource constraints. This study assessed the predictive value of delta-Sequential Organ Failure Assessment (SOFA) scores on days 2, 3 and 5, both independently and combined with Simplified Acute Physiology Score (SAPS) 3, for in-hospital mortality. Methods A retrospective cohort study analysed ICU patients with stays of≥5 days from 2018 to 2020. Clinical data included SAPS 3 and SOFA scores at admission, 48 hours and on days 3 and 5, alongside mortality outcomes. Logistic regression and discriminant analysis identified mortality predictors and evaluated model performance. Results Among 200 patients, 26% died in hospital. Non-survivors had significantly higher SAPS 3 scores (mean 51.9±11.9 vs 45.6±11.9 in survivors, p=0.001) and worsening SOFA scores, particularly on days 3 and 5. Combining SAPS 3 with delta-SOFA on day 5 produced an area under the receiver operating characteristic (AUROC) of 0.71 (95% CI: 0.63 to 0.79), indicating moderate predictive ability. Conclusions Integrating the delta-SOFA score on day 5 with SAPS 3 improves in-hospital mortality predictions during prolonged ICU stays. Findings suggest early treatment limitations within 48 hours may be premature, as patient responses evolve and shared decision-making becomes more feasible over time.
- Open Access
- 15 November 2024
- Published by Gobierno de Navarra in Anales del Sistema Sanitario de Navarra
- Vol. 47 (3)
Diagnostic comparison of bedside lung ultrasound and chest radiography in the intensive care unit
Bedside lung ultrasound (POCUS) offers advantages over chest X-ray, including better cost-effectiveness for diagnosing certain pulmonary pathologies. This study compares the diagnostic concordance between portable chest X-rays and bedside lung ultrasounds in the intensive care unit (ICU). Adult ICU patients were included. POCUS was performed using the abbreviated BLUE protocol. Diagnostic results from POCUS and chest radiographies were compared using the intensivist clinical diagnosis - based on clinical examinations and lung ultrasounds - as the reference. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the ultrasounds were calculated. A total of 100 patients were included, 71 with pulmonary pathologies. The average time to perform the ultrasound was 308 seconds. Ultrasound identified pathology in 20 patients with a normal chest radiographs. Diagnostic discrepancies occurred in 30 patients, highlighting ultrasound´s superior sensitivity in detecting atelectasis, pleural effusions, and pulmonary edema. Ultrasound demonstrated sensitivity (S) of 85%, specificity (E) of 100%, positive predictive value (PPV) of 100%, and negative predictive value (NPV) of 55%. Lung point-of-care ultrasound at ICU admission detects more pathologies and does not miss significant abnormalities seen on chest X-rays. It also shows good diagnostic accuracy. These findings suggest that pulmonary POCUS, using an abbreviated protocol, could be a viable alternative to chest radiography for initial evaluation and follow-up of pulmonary pathologies in critically ill patients, potentially improving care quality and management.
- 15 November 2024
- Published by Gobierno de Navarra in Anales del Sistema Sanitario de Navarra
- Vol. 47 (3)
Open AccessDiagnostic comparison of bedside lung ultrasound and chest radiography in the intensive care unit
Bedside lung ultrasound (POCUS) offers advantages over chest X-ray, including better cost-effectiveness for diagnosing certain pulmonary pathologies. This study compares the diagnostic concordance between portable chest X-rays and bedside lung ultrasounds in the intensive care unit (ICU). Adult ICU patients were included. POCUS was performed using the abbreviated BLUE protocol. Diagnostic results from POCUS and chest radiographies were compared using the intensivist clinical diagnosis - based on clinical examinations and lung ultrasounds - as the reference. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the ultrasounds were calculated. A total of 100 patients were included, 71 with pulmonary pathologies. The average time to perform the ultrasound was 308 seconds. Ultrasound identified pathology in 20 patients with a normal chest radiographs. Diagnostic discrepancies occurred in 30 patients, highlighting ultrasound´s superior sensitivity in detecting atelectasis, pleural effusions, and pulmonary edema. Ultrasound demonstrated sensitivity (S) of 85%, specificity (E) of 100%, positive predictive value (PPV) of 100%, and negative predictive value (NPV) of 55%. Lung point-of-care ultrasound at ICU admission detects more pathologies and does not miss significant abnormalities seen on chest X-rays. It also shows good diagnostic accuracy. These findings suggest that pulmonary POCUS, using an abbreviated protocol, could be a viable alternative to chest radiography for initial evaluation and follow-up of pulmonary pathologies in critically ill patients, potentially improving care quality and management.
- Open Access
- 5 August 2024
- Published by Gobierno de Navarra in Anales del Sistema Sanitario de Navarra
- Vol. 47 (2)
Biomarkers of oxidative stress and inflammation in contrast-associated acute kidney injury
Iodinated contrast-induced acute kidney injury (CI-AKI) is a common cause of renal failure, especially in patients with risk factors. This study analyses different renal biomarkers in patients undergoing computed tomography scans with iodinated contrast to identify the molecular and cellular mechanisms involved in the pathogenesis of CI-AKI. Prospective study that included patients with high risk of renal disease who received iodinated contrast (iohexol) for the computed tomography scans. Functional biomarkers (creatinine and cystatin C), inflammatory and oxidative stress markers (neutrophil gelatinase-associated lipocalin [NGAL], interleukin-8 [IL-8], superoxide dismutase [SOD], F2-isoprostanes, and cardiotrophin-1), and cell cycle biomarkers (Nephrocheck®) were analysed before the iodinated contrast and 4, 12, 24, and 48 hours post-contrast, in relation to the incidence of IC-AKI. IC-AKI was observed in 30.6% of the 62 study participants and in 57.1% of the patients with diabetes and renal dysfunction. Factors associated with IC-AKI were a higher mean age (74.4 vs 64.9 years), pre-existing renal dysfunction (60 vs 16.7%), and higher adjusted mean volume of iohexol (42.9 vs 32.1%). As for non-functional biomarkers. No differences were found between patients with and without CI-AKI. The use of iodinated contrast was associated with a decrease in SOD antioxidant activity at 4 hours and an increase in IL-8 at 12 hours post-administration of the iodinated contrast. Administration of iohexol in computed tomography scans in patients with high risk of renal disease results in an elevated percentage of CI-AKI, attributable to ischemia/reperfusion injury and/or direct toxicity of the iodinated contrast.
- 5 August 2024
- Published by Gobierno de Navarra in Anales del Sistema Sanitario de Navarra
- Vol. 47 (2)
Open AccessBiomarkers of oxidative stress and inflammation in contrast-associated acute kidney injury
Iodinated contrast-induced acute kidney injury (CI-AKI) is a common cause of renal failure, especially in patients with risk factors. This study analyses different renal biomarkers in patients undergoing computed tomography scans with iodinated contrast to identify the molecular and cellular mechanisms involved in the pathogenesis of CI-AKI. Prospective study that included patients with high risk of renal disease who received iodinated contrast (iohexol) for the computed tomography scans. Functional biomarkers (creatinine and cystatin C), inflammatory and oxidative stress markers (neutrophil gelatinase-associated lipocalin [NGAL], interleukin-8 [IL-8], superoxide dismutase [SOD], F2-isoprostanes, and cardiotrophin-1), and cell cycle biomarkers (Nephrocheck®) were analysed before the iodinated contrast and 4, 12, 24, and 48 hours post-contrast, in relation to the incidence of IC-AKI. IC-AKI was observed in 30.6% of the 62 study participants and in 57.1% of the patients with diabetes and renal dysfunction. Factors associated with IC-AKI were a higher mean age (74.4 vs 64.9 years), pre-existing renal dysfunction (60 vs 16.7%), and higher adjusted mean volume of iohexol (42.9 vs 32.1%). As for non-functional biomarkers. No differences were found between patients with and without CI-AKI. The use of iodinated contrast was associated with a decrease in SOD antioxidant activity at 4 hours and an increase in IL-8 at 12 hours post-administration of the iodinated contrast. Administration of iohexol in computed tomography scans in patients with high risk of renal disease results in an elevated percentage of CI-AKI, attributable to ischemia/reperfusion injury and/or direct toxicity of the iodinated contrast.
- 12 June 2024
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 41 (7) , 543-544
Number of anaesthesia residents in Spain: correction to publication by Berger-Estilita J, et al.
- 12 June 2024
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 41 (7) , 543-544
Number of anaesthesia residents in Spain: correction to publication by Berger-Estilita J, et al.
- Open Access
- 11 December 2023
- Published by Springer Nature in Critical Care
- Vol. 27 (1) , 1
Publisher Correction: Early corticosteroids are associated with lower mortality in critically ill patients with COVID‑19: a cohort study
- 11 December 2023
- Published by Springer Nature in Critical Care
- Vol. 27 (1) , 1
Open AccessPublisher Correction: Early corticosteroids are associated with lower mortality in critically ill patients with COVID‑19: a cohort study
- 9 August 2021
- Published by BMJ in BMJ Supportive & Palliative Care
- Vol. 12 (2) , 198
Euthanasia is not medicine
- 9 August 2021
- Published by BMJ in BMJ Supportive & Palliative Care
- Vol. 12 (2) , 198
Euthanasia is not medicine
- 1 August 2021
- Published by Elsevier in Revista Española de Anestesiología y Reanimación (English Edition)
- Vol. 68 (7) , 430-431
Reply to the letter: “Intensive care in Spain” A. Suárez-de-la-Rica, G. Aguilar and E. Maseda. DOI: 10.1016/j.redar.2020.06.002
- 1 August 2021
- Published by Elsevier in Revista Española de Anestesiología y Reanimación (English Edition)
- Vol. 68 (7) , 430-431
Reply to the letter: “Intensive care in Spain” A. Suárez-de-la-Rica, G. Aguilar and E. Maseda. DOI: 10.1016/j.redar.2020.06.002